⌘K
Loading ticker…
As of 2026-08-21, Kiora Pharmaceuticals, Inc. Common Stock (KPRX) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.7%, relative volume 0.76×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
KPRX is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 3.7% / 15.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
KPRX appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $38K notional.
Held by 1 ETFs · $38K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $38K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KPRX Jan avg: 13.15% median: 13.79% win: 100% σ: 10.25% n: 4 2022-04-12 → 2026-07-31 | KPRX Feb avg: 3.82% median: 4.28% win: 50% σ: 23.26% n: 4 2022-04-12 → 2026-07-31 | KPRX Mar avg: -8.69% median: -7.52% win: 25% σ: 12.39% n: 4 2022-04-12 → 2026-07-31 | KPRX Apr avg: 4.85% median: 6.98% win: 60% σ: 24.46% n: 5 2022-04-12 → 2026-07-31 | KPRX May avg: -13.05% median: -7.45% win: 20% σ: 24.98% n: 5 2022-04-12 → 2026-07-31 | KPRX Jun avg: -14.57% median: -3.36% win: 20% σ: 30.92% n: 5 2022-04-12 → 2026-07-31 | KPRX Jul avg: -15.64% median: -7.29% win: 20% σ: 30.67% n: 5 2022-04-12 → 2026-07-31 | KPRX Aug avg: 0.63% median: -4.77% win: 50% σ: 24.18% n: 4 2022-04-12 → 2026-07-31 (current) | KPRX Sep avg: -1.99% median: -0.54% win: 25% σ: 14.37% n: 4 2022-04-12 → 2026-07-31 | KPRX Oct avg: -1.81% median: 1.42% win: 50% σ: 10.58% n: 4 2022-04-12 → 2026-07-31 | KPRX Nov avg: -20.63% median: -13.30% win: 0% σ: 16.98% n: 4 2022-04-12 → 2026-07-31 | KPRX Dec avg: -0.42% median: 0.24% win: 50% σ: 2.12% n: 4 2022-04-12 → 2026-07-31 |